financetom
Business
financetom
/
Business
/
Filo Closes $115 Million Private Placement
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Filo Closes $115 Million Private Placement
Aug 7, 2024 7:22 AM

10:02 AM EDT, 08/07/2024 (MT Newswires) -- Filo ( FLMMF ) on Wednesday closed its previously announced private placement of near 3.48 million common shares in the capital of the company at $33 per share for near $115 million.

A statement noted the private placement was made pursuant to subscription agreements entered into between Filo ( FLMMF ) and each of BHP and Lundin Mining ( LUNMF ) .

Each of BHP's and Lundin's equity interest in the company has increased by approximately 1.3%, resulting in each of them now owning, directly or indirectly, approximately 7.1% and 1.7%, respectively, and the company now has 134.6 million Filo ( FLMMF ) shares issued and outstanding.

The private placement entails a dilution of approximately 2.6% of the number of shares and votes in the company.

The net proceeds of the private placement will be used for exploration of the Filo ( FLMMF ) del Sol project, general working capital expenses and general and administration expenses for the period between announcement and closing of the transaction, in accordance with Filo's ( FLMMF ) budget.

Price: 30.90, Change: -0.06, Percent Change: -0.19

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BioNTech, Bristol Myers Squibb Report Tumor Shrinkage in Phase 2 Pumitamig Study
BioNTech, Bristol Myers Squibb Report Tumor Shrinkage in Phase 2 Pumitamig Study
Sep 8, 2025
11:43 AM EDT, 09/08/2025 (MT Newswires) -- BioNTech (BNTX) and Bristol Myers Squibb ( BMY ) said Monday that interim phase 2 data for pumitamig plus chemotherapy showed tumor shrinkage of 56.7% in patients with extensive-stage small cell lung cancer. Of 43 patients enrolled in the trial, 38 were efficacy-evaluable who received pumitamig in combination with chemotherapy in two dose...
Top Midday Stories: PNC Acquires FirstBank for $4.10 Billion; EchoStar Sells Spectrum Licenses to SpaceX for $17 Billion
Top Midday Stories: PNC Acquires FirstBank for $4.10 Billion; EchoStar Sells Spectrum Licenses to SpaceX for $17 Billion
Sep 8, 2025
11:39 AM EDT, 09/08/2025 (MT Newswires) -- All three major US stock indexes were up in late-morning trading Monday, as investors looked ahead to two critical inflation data releases later this week. In company news, PNC Financial Services Group ( PNC ) said Monday it has agreed to buy FirstBank Holding in a deal valued at $4.10 billion. The purchase...
PharmaCorp Rx to Acquire Ontario Pharmacy for $5.3 Million
PharmaCorp Rx to Acquire Ontario Pharmacy for $5.3 Million
Sep 8, 2025
11:43 AM EDT, 09/08/2025 (MT Newswires) -- PharmaCorp Rx (PCRX.V) on Monday said it is acquiring a PharmaChoice Canada-bannered pharmacy business in Ontario for $5.3 million. The transaction, which is expected to close around Oct. 1, is PharmaCorp's first acquisition under its charter company structure, which was gained through the purchase of a pre-1954 charter company on April 30. A...
BRIEF-LB Pharmaceuticals Sees IPO Of 16.7 Mln Shares Of Common Stock
BRIEF-LB Pharmaceuticals Sees IPO Of 16.7 Mln Shares Of Common Stock
Sep 8, 2025
Sept 8 (Reuters) - LB Pharmaceuticals Inc: * LB PHARMACEUTICALS SEES IPO OF 16.7 MILLION SHARES OF COMMON STOCK - SEC FILING * LB PHARMACEUTICALS INC - IPO OF 16,666,667 SHARES AT $14-$16 PER SHARE - SEC FILING Source text: ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved